APA (7th ed.) Citation

Kexin Ling, Huli Qin, Yiman Feng, Hongxi Che, Jinxi Ding, Jinxi Ding, . . . Wei Li. (2022). Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Kexin Ling, Huli Qin, Yiman Feng, Hongxi Che, Jinxi Ding, Jinxi Ding, Wei Li, and Wei Li. Correlation Between Clinical Trial Endpoints of Marketed Cancer Drugs and Reimbursement Decisions in China. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Kexin Ling, et al. Correlation Between Clinical Trial Endpoints of Marketed Cancer Drugs and Reimbursement Decisions in China. Frontiers Media S.A., 2022.